1. Home
  2. HLLY vs LCTX Comparison

HLLY vs LCTX Comparison

Compare HLLY & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Holley Inc.

HLLY

Holley Inc.

HOLD

Current Price

$2.38

Market Cap

306.9M

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.35

Market Cap

301.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLLY
LCTX
Founded
1903
1990
Country
United States
United States
Employees
1483
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
306.9M
301.7M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
HLLY
LCTX
Price
$2.38
$1.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
4
Target Price
$4.83
$6.25
AVG Volume (30 Days)
858.5K
2.1M
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,556,000.00
Revenue This Year
$6.32
$109.40
Revenue Next Year
$4.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.24
52 Week Low
$1.98
$0.93
52 Week High
$4.48
$2.09

Technical Indicators

Market Signals
Indicator
HLLY
LCTX
Relative Strength Index (RSI) 40.62 56.41
Support Level N/A N/A
Resistance Level $2.65 $1.80
Average True Range (ATR) 0.11 0.06
MACD 0.01 0.02
Stochastic Oscillator 21.88 82.41

Price Performance

Historical Comparison
HLLY
LCTX

About HLLY Holley Inc.

Holley Inc designs, manufactures, and distributes high-performance automotive aftermarket products to car and truck enthusiasts in the United States, Canada and Europe. It manufactures a diversified line of performance automotive products, including carburetors, fuel pumps, fuel injection systems, nitrous oxide injection systems, superchargers, exhaust headers, mufflers, distributors, ignition components, engine tuners and automotive performance plumbing products. It also manufactures exhaust products as well as shifters, converters, transmission kits, transmissions, tuners and automotive software. The company markets its products under brands such as Holley, Holley EFI, MSD, Simpson, Flowmaster, EDGE, Cataclean, and Accel, among others. It operates in single segment.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: